These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9322954

  • 1. Regulation of osteoclastogenesis by antisense oligodeoxynucleotides specific to zinc finger nuclear transcription factors Egr-1 and WT1 in rat bone marrow culture system.
    Kukita T, Kukita A, Harada H, Iijima T.
    Endocrinology; 1997 Oct; 138(10):4384-9. PubMed ID: 9322954
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system.
    Xu LX, Kukita T, Kukita A, Otsuka T, Niho Y, Iijima T.
    J Cell Physiol; 1995 Dec; 165(3):624-9. PubMed ID: 7593242
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage.
    Nguyen HQ, Hoffman-Liebermann B, Liebermann DA.
    Cell; 1993 Jan 29; 72(2):197-209. PubMed ID: 7678779
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Catalytic antisense DNA molecules targeting Egr-1 inhibit neointima formation following permanent ligation of rat common carotid arteries.
    Lowe HC, Chesterman CN, Khachigian LM.
    Thromb Haemost; 2002 Jan 29; 87(1):134-40. PubMed ID: 11848443
    [Abstract] [Full Text] [Related]

  • 9. Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis.
    Carl M, Akagi Y, Weidner S, Isaka Y, Imai E, Rupprecht HD.
    Kidney Int; 2003 Apr 29; 63(4):1302-12. PubMed ID: 12631347
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
    Lee YI, Kim SJ.
    DNA Cell Biol; 1996 Feb 29; 15(2):99-104. PubMed ID: 8634146
    [Abstract] [Full Text] [Related]

  • 11. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ.
    Biochemistry; 1996 Sep 17; 35(37):12070-6. PubMed ID: 8810912
    [Abstract] [Full Text] [Related]

  • 12. Expression of the transcriptional regulator Egr-1 in experimental glomerulonephritis: requirement for mesangial cell proliferation.
    Rupprecht HD, Hoffer G, de Heer E, Sterzel RB, Faller G, Schoecklmann HO.
    Kidney Int; 1997 Mar 17; 51(3):694-702. PubMed ID: 9067901
    [Abstract] [Full Text] [Related]

  • 13. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
    Okahashi N, Murase Y, Koseki T, Sato T, Yamato K, Nishihara T.
    J Cell Biochem; 2001 Mar 17; 80(3):339-45. PubMed ID: 11135363
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V, Kranenburg O, van der Eb AJ, Jochemsen AG.
    Cell Growth Differ; 1997 Feb 17; 8(2):133-43. PubMed ID: 9040935
    [Abstract] [Full Text] [Related]

  • 15. c-fos antisense DNA inhibits proliferation of osteoclast progenitors in osteoclast development but not macrophage differentiation in vitro.
    Udagawa N, Chan J, Wada S, Findlay DM, Hamilton JA, Martin TJ.
    Bone; 1996 Jun 17; 18(6):511-6. PubMed ID: 8805990
    [Abstract] [Full Text] [Related]

  • 16. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
    Williams SA, Gillan ER, Knoppel E, Buzby JS, Suen Y, Cairo MS.
    Ann Oncol; 1997 Jun 17; 8 Suppl 1():25-30. PubMed ID: 9187425
    [Abstract] [Full Text] [Related]

  • 17. Transcription factor Egr-1 regulates glomerular mesangial cell proliferation.
    Hofer G, Grimmer C, Sukhatme VP, Sterzel RB, Rupprecht HD.
    J Biol Chem; 1996 Nov 08; 271(45):28306-10. PubMed ID: 8910451
    [Abstract] [Full Text] [Related]

  • 18. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.
    Algar EM, Khromykh T, Smith SI, Blackburn DM, Bryson GJ, Smith PJ.
    Oncogene; 1996 Mar 07; 12(5):1005-14. PubMed ID: 8649791
    [Abstract] [Full Text] [Related]

  • 19. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A, Hemmi H, Akira S, Bar-Shavit Z.
    J Bone Miner Res; 2005 Sep 07; 20(9):1692-9. PubMed ID: 16059640
    [Abstract] [Full Text] [Related]

  • 20. Early growth response-1 is involved in foam cell formation and is upregulated by the TLR9-MyD88-ERK1/2 pathway.
    Kim JS, Park DW, Lee HK, Kim JR, Baek SH.
    Biochem Biophys Res Commun; 2009 Dec 11; 390(2):196-200. PubMed ID: 19737531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.